Myfembree 40 MG-1 MG-0.5 MG TB 28S
Ended Awarded
- Contract number
- SPE2DB26FR1QQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,543
Award facts
- Contract value 100% obligated
- $4,543.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $4,543.25 firm fixed-price delivery order to AmerisourceBergen Drug Corp for MYFEMBREE pharmaceutical products (40 mg, 1 mg, and 0.5 mg tablets in a 28-count package) on October 30, 2025, with an ultimate completion date of October 31, 2025. The contract was competitively awarded with no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp serves as a major pharmaceutical distributor and critical federal medical procurement vendor, supplying a comprehensive range of medications and medical supplies to support military and veteran healthcare systems. The company's extensive federal contract portfolio with the DLA encompasses diverse therapeutic domains including diabetes medications, neurological treatments, pain management pharmaceuticals, antibiotics, and specialized medical supplies. The SPE2DX prime contract vehicle enables AmerisourceBergen to deliver pharmaceutical products globally to support Defense Health Agency operations and other government healthcare systems, positioning the contractor as a key component of the federal medical supply chain infrastructure.
Quick answers
Who was awarded contract SPE2DB26FR1QQ?
SPE2DB26FR1QQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 30, 2025.
How much is contract SPE2DB26FR1QQ worth?
The government has obligated $4,543 on SPE2DB26FR1QQ.
Is contract SPE2DB26FR1QQ an order under another contract?
Yes. SPE2DB26FR1QQ is a delivery order under SPE2DB22D2218, an indefinite delivery contract.
Was contract SPE2DB26FR1QQ competed?
The extent of competition for SPE2DB26FR1QQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award